Botox restrictions for minors

By Admin
Share
Under 18-year-olds in New Jersey will not be able to have Botox injections without a doctors note to prove it is medically necessary under a new US hea...

Under 18-year-olds in New Jersey will not be able to have Botox injections without a doctor’s note to prove it is medically necessary under a new US healthcare bill.

It is hoped that the move will eradicate the growing trend of minors undergoing Botox injections for cosmetic purposes.

The legislation has been approved by the Assembly Health and Senior Services Committee and the bill cites an example found in a study by the American Society for Aesthetic Plastic Surgery as its argument.

The study found that teenagers had more than 12,000 Botox injections in 2009; more than double the number from 2008.

It is thought the bill was pushed forward through the Assembly after a mother from California appeared on television saying she gave her eight-year-old daughter Botox injections while she was competing in beauty pageants.

Botox is a prescription medication and Botox injections are considered a cosmetic surgery treatment.

They are commonly used to smooth wrinkles and fine lines although can also be used to cure headaches and spasms.

Botox works by paralysing the facial muscles but if it spreads beyond the injection site it can lead to side effects such as problems with breathing, swallowing and speaking.   

There have even been reports of death associated Botox use.

Existing federal and state legislation already restricts the administration of Botox treatments to minors, however if passed, the new bill would require a professional medical document outlining the patients non-cosmetic need for the injections.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma